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Aim TTo assess the effects of preoperative calcium levels 
and parathyroidectomy on estimated glomerular filtra-
tion rate (eGFR) in patients with primary hyperparathy-
roidism (PHPT) with mild renal dysfunction or normal re-
nal function.
Methods This retrospective study enrolled 71 patients 
who underwent parathyroidectomy for PHPT in the Gen-
eral Surgery Department at Ondokuz Mayis University 
Hospital from 2010 to 2018. All patients were histopatho-
logically diagnosed with parathyroid adenoma. Total se-
rum calcium, serum creatinine, serum intact parathyroid 
hormone (PTH), and serum 25-hydroxyvitamin D3 (25(OH)
D3) were measured before and 3-6 months after surgery. 
Patients were assigned to the low eGFR group (60-90 mL/
min/1.73 m2) or normal eGFR group (≥90 mL/min/1.73 m2) 
and to the low calcium group (≤11.2 mg/dL) or high cal-
cium group (>11.2 mg/dL).
Results In the low eGFR and high calcium group, there 
were significantly more patients with hypertension and 
older age. In the normal eGFR and high calcium group, 
eGFR was significantly reduced after surgery. Independent 
predictors of eGFR change after surgery were age, pre- 
parathyroidectomy calcium, and pre-parathyroidectomy 
eGFR.
Conclusions After surgery, patients with low eGFR had 
preserved renal function, whereas those with normal eGFR 
had decreased renal function. Mild renal dysfunction in 
PHPT was associated with older age, hypertension, and 
high calcium levels.
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Primary hyperparathyroidism (PHPT) is a common endocrine 
disorder characterized by hypercalcemia and high or inap-
propriately normal parathyroid hormone (PTH) levels (1). It 
is most frequently caused by a single parathyroid adenoma, 
followed by parathyroid gland hyperplasia and parathyroid 
carcinomas (2). Patients with PHPT experience renal compli-
cations such as nephrolithiasis and hypercalciuria (3). Further-
more, in these patients high serum calcium and PTH levels 
may negatively affect the renal function (3). Although chron-
ic renal failure mainly leads to secondary hyperparathyroid-
ism, about 16%-17% of patients with PHPT have low glom-
erular filtration rates (eGFR<60 mL/min/1.73 m2) (1,4). Thus, 
a decrease in eGFR can be expected during a course of un-
treated PHPT. An eGFR below 60 mL/min/1.73 m2 is a surgical 
indication for parathyroidectomy (5). While some studies (5,6) 
reported that parathyroidectomy improved renal function in 
PHPT patients with eGFR below 60 mL/min/1.73 m2 pre-sur-
gery, others reported no effect (7-12). However, the effect of 
parathyroidectomy on eGFR in patients with eGFR≥60 mL/
min/1.73 m2 is not clear due to the scarcity of the studies on 
this issue (1,4,5,13,14). Moreover, the existing studies differ in 
terms of patient selection and methodology and report dif-
ferent factors affecting GFR. The aim of the present study was 
to assess the effects of preoperative calcium levels and para-
thyroidectomy on renal function in patients with PHPT, with 
mild renal dysfunction or normal renal function.
PatientS and methodS
Study population
We retrospectively reviewed the records of all patients who 
underwent surgery due to PHPT in the General Surgery De-
partment of the Ondokuz Mayis University Hospital from 
2010 to 2018. All patients had histologically and pathologi-
cally confirmed parathyroid adenoma. None of the patients 
had advanced kidney failure (eGFR<60 mL/min/1.73 m2). All 
the surgeries were performed by the same surgical team. 
The pre-parathyroidectomy eGFR level ≥60 mL/min/1.73 m2 
was used to eliminate the effects of moderate to severe re-
nal insufficiency on the PTH hormonal axis.
Inclusion criteria were age 18 years and older, complete 
medical records with a full patient history, available re-
sults of a physical examination, and available values of to-
tal serum calcium, serum creatinine, serum intact PTH, and 
serum 25-hydroxyvitamin D3 (25(OH)D3) before and 3-6 
months after parathyroidectomy. Exclusion criteria were 
the diagnosis of multiple endocrine neoplasia type 1 
and 2 or any active malignancies, including thyroid 
or parathyroid carcinomas diagnosed during parathyroi-
dectomy, and thyroid or hepatic dysfunction. The final 
sample consisted of 71 patients (91.5% women).
The patients were divided into two groups according to Kid-
ney Disease: Improving Global Outcomes guidelines (15): 
those with a mild decrease in eGFR (low eGFR group: 60-
90 mL/min/1.73 m2) and those with a normal or increased 
eGFR (normal eGFR group: ≥90 mL/min/1.73 m2). One of 
the surgical criteria for PHPT is an increase in serum calcium 
level 1 mg/dL above the upper reference limit. Therefore, 
the patients were divided into low calcium group (≤11.2 
mg/dL) and high calcium group (> 11.2 mg/dL) for the pur-
pose of assessing the effect of calcium levels on eGFR.
This study was approved by the Medical Ethics Commit-
tee of Ondokuz Mayis University (OMU-KAEK 2018/296). 
The patients gave informed consent for the testing as part 
of their regular medical care. Demographic data, medical 
histories, histological examinations, laboratory studies, and 
imaging were obtained from the hospital database.
Biochemical evaluation
Serum calcium and creatinine were measured with colori-
metric and spectrophotometric methods by using Roche 
Cobas 8000 modular analyzer (Roche Diagnostics, Man-
nheim, Germany). Serum intact PTH was measured with 
electrochemiluminescence immunoassay method by us-
ing Roche Cobas E170 modular analyzer (Roche Diagnos-
tics). Serum 25(OH)D3 was measured with high perfor-
mance liquid chromatography (HPLC) by using Agilent 
1100 Series (Chromsystem Diagnostics, Munich, Germany). 
Intra-assay and inter-assay coefficient of variations were 
4.8% and 6.3%, respectively.
eGFR was assessed with the Chronic Kidney Disease Epide-
miology Collaboration creatinine equation (15): 141 × min 
(SCr/К, 1)α × max(SCr/К, 1)1.209 × 0.993Age ( × 1.018 if female), 
where SCr is serum creatinine (in mg/dL), К is 0.7 for wom-
en and 0.9 for men, α is -0.329 for women and -0.411 for 
men, min is the minimum of SCr/κ or 1, and max is the 
maximum of SCr/κ or 1.
Statistical analysis 
The normality of distribution was tested either by Shapiro-
Wilk or Kolmogorov-Smirnov tests according to the num-
ber of participants in the total group and subgroups. The 
results are presented as mean ± standard deviation or me-
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dian and interquartile range (IQR). The significance of dif-
ferences between the groups for unpaired samples (eGFR 
and calcium groups) was tested with the Mann-Whitney 
U test or independent sample t test and for paired sam-
ples (pre-post PTX comparisons) with the Wilcoxon’s test 
or paired t test, where applicable. The significance of dif-
ferences between the categorical variables was assessed 
with the chi square test or Fisher exact test, where applica-
ble. The correlation between continuous variables was as-
sessed with the Pearson correlation test or Spearman corre-
lation test, where applicable. Multiple linear regression was 
used to evaluate independent predictors of eGFR change. 
Backward elimination method in multiple linear regression 
was used to predict the most significant model that ex-
plains the factors related to eGFR change. The level of sig-
nificance was set at P ≤ 0.05. The analysis was conducted 
with SPSS, version 25.0 (IBM Corp., Armonk, NY, USA).
ReSultS
The mean age was 52.8 ± 12.1. Hypertension was present 
in 40.8%, diabetes mellitus (DM) in 16.9%, and nephro-
lithiasis in 18.3% patients. The mean eGFR was 97.7 ± 19.5 
mL/min before parathyroidectomy and 95.5 ± 19.8 mL/min 
after parathyroidectomy. Serum calcium and PTH signifi-
cantly decreased after parathyroidectomy, serum creati-
nine and 25(OH)D3 significantly increased, while eGFR did 
not change significantly (Table 1).
taBle 1. Clinical data of primary hyperparathyroidism patients before and after parathyroidectomy*
Before parathyroidectomy,
mean±Sd or median (iQR)
after parathyroidectomy,
mean±Sd or median (iQR) P
Age, years  52.8 ± 12.1
Serum creatinine (RR: 0.4-1.4 mg/dL)   0.69 ± 0.16  0.72 ± 0.18   0.032†
Serum calcium (RR: 8.8-10.2 mg/dL)  11.3 ± 0.75  9.5 ± 0.41 <0.001†
Parathyroid hormone (RR: 15-65 pg/mL) 167.1 (108.7) 65.3 (27.9) <0.001‡
25-hydroxyvitamin D3 (RR: 30-80 μg/L)  17.6 (14.3) 20.8 (6.53)   0.036
‡
Estimated glomerular filtration rate (mL/min/1.73 m2)  97.7 ± 19.5 95.5 ± 19.8   0.1†
*Sd – standard deviation; iQR – interquartile range; RR – reference range.
†t-test.
‡Wilcoxon’s test for paired samples.
taBle 2. Clinical data of primary hyperparathyroidism patients subdivided according to preoperative estimated glomerular filtration 
rate (eGFR)*
low eGFR (60≤eGFR<90) (n = 23) normal eGFR (eGFR≥90) (n = 48) P
Female sex, n (%)  21 (91.3)  44 (91.7) 0.959§
hypertension, n (%)  14 (60.9)  15 (31.3) 0.017§
diabetes mellitus, n (%)   5 (21.7)   7 (14.6) 0.451§
nephrolithiasis, n (%)   6 (26.1)   7 (14.6) 0.241§
age (years), mean±Sd  62.8 ± 8.1  48.0 ± 10.7 <0.001†
Before parathyroidectomy
Serum creatinine (mg/dL), mean±SD   0.85 ± 0.12   0.62 ± 0.11 <0.001†
Serum calcium (mg/dL), mean±SD  11.7 ± 0.9  11.2 ± 0.6 0.012†
Parathyroid hormone (pg/mL), median (IQR) 154.4 (69.1) 179 (116.0) 0.589‡
25-hydroxyvitamin D3 (μg/L), median (IQR)  20.7 (12.8)  14.8 (17.0) 0.033‡
eGFR (mL/min/1.73 m2), mean±SD  75.4 ± 9.8 108.4 ± 12.7 <0.001†
after parathyroidectomy
Serum creatinine (mg/dL), mean±SD   0.86 ± 0.19   0.66 ± 0.13 <0.001†
Serum calcium (mg/dL), mean±SD   9.5 ± 0.4   9.5 ± 0.4 0.852†
Parathyroid hormone (pg/mL), median (IQR)  78.9 (54.3)  64.2 (27.4) 0.094‡
25-hydroxyvitamin D3 (μg/L), median (IQR)  22.8 (17.0)  20.4 (6.4) 0.273
‡
eGFR (mL/min/1.73 m2), mean±SD  77.2 ± 16.8 104.3 ± 14.6 <0.001†
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The low eGFR group and normal eGFR group did not sig-
nificantly differ in sex, nephrolithiasis rate, and DM rate. 
However, the low eGFR group had a significantly higher 
hypertension rate (P = 0.017) and was significantly old-
er (P < 0.001). The low eGFR group also had significantly 
higher pre-parathyroidectomy 25(OH)D3, pre-parathy-
roidectomy calcium, and post-parathyroidectomy crea-
tinine, and significantly lower post-parathyroidectomy 
eGFR (Table 2). In the normal eGFR group, eGFR was sig-
nificantly reduced after parathyroidectomy (P = 0.005) 
but in the low eGFR group it did not change signifi-
cantly (P = 0.522, paired sample t test, data not shown). 
There were 4 patients with unchanged, 22 patients with 
decreased, and 45 patients with increased postoperative 
eGFR levels.
The low calcium group and high calcium group did not 
significantly differ in sex and DM rate. The high calcium 
group had significantly higher mean age, nephrolithiasis 
rate, and hypertension rate. It also had significantly higher 
creatinine and calcium levels both before and after para-
thyroidectomy, and significantly lower pre-parathyroidec-
tomy eGFR (Table 3). In the low calcium group, eGFR did 
not change after parathyroidectomy (P = 0.850), but in the 
taBle 3. Clinical data of primary hyperparathyroidism patients subdivided according to serum calcium
low serum calcium 
(≤11.2 mg/dl) (n = 35)
high serum calcium 
(>11.2 mg/dl) (n = 36) P
Female, n (%)  33 (94.3)  32 (88.9)  0.414§
hypertension, n (%)   8 (22.9)  21 (58.3)  0.02§
diabetes mellitus, n (%)   3 (8.6)   9 (25)  0.065§
nephrolithiasis, n (%)   2 (5.7)  11 (30.6)  0.007§
age (years), mean±Sd  48.7 ± 12.6  56.8 ± 10.3  0.004†
Before parathyroidectomy
Serum creatinine (mg/dL), mean±SD   0.64 ± 0.16   0.74 ± 0.14  0.006†
Serum calcium (mg/dL), mean±SD  10.8 ± 0.38  11.9 ± 0.59 <0.001†
Parathyroid hormone (pg/mL), median (IQR) 141.3 (124.1) 182.0 (83.1)  0.182‡
25-hydroxyvitamin D3 (μg/L), median (IQR)  16.5 (10.6)  19.3 (18.5)  0.412
‡
eGFR (mL/min/1.73 m2), mean±SD 105.1 ± 19.1  90.5 ± 17.3  0.001†
after parathyroidectomy
Serum creatinine (mg/dL), mean±SD   0.65 ± 0.14   0.79 ± 0.19  0.001†
Serum calcium (mg/dL), mean±SD   9.38 ± 0.42   9.64 ± 0.37  0.007†
Parathyroid hormone (pg/mL), median (IQR)  65.2 (25.9)  65.3 (40.5)  0.321‡
25-hydroxyvitamin D3 (μg/L), median (IQR)  22.6 (5.9)  20.5 (9.9)  0.291
‡
eGFR (mL/min/1.73 m2), median (IQR) 104.0 (27)  86.5 ± 19.1 <0.001†




taBle 4. Correlation between laboratory parameters and pre- and post-parathyroidectomy estimated glomerular filtration rate (eGFR)
Pre- parathyroidectomy
eGFR age creatinine calcium parathyroid hormone 25-hydroxyvitamin d3
Pre-parathyroidectomy eGFR
correlation coefficient  -  -0.760*  -0.888* -0.290† 0.168 -0.296†
significance (two-tailed)  - <0.001‡ <0.001‡  0.014‡ 0.161§  0.027§
Post-parathyroidectomy eGFR
correlation coefficient  0.835*  -0.717*  -0.739* -0.385* 0.079 -0.255
significance (two-tailed) <0.001‡ <0.001‡ <0.001‡  0.001‡ 0.514§  0.058§
*Correlation is significant at the 0.01 level (two-tailed).
†Correlation is significant at the 0.05 level (two-tailed).
‡Pearson correlation.
§Spearman correlation.
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high calcium group it was significantly reduced (P = 0.022) 
(paired sample t test, not shown in the table).
Pre-parathyroidectomy eGFR negatively correlated with 
age, pre-parathyroidectomy calcium, creatinine, and 
25(OH)D3 whereas post-parathyroidectomy eGFR nega-
tively correlated with age, and pre-parathyroidectomy cal-
cium and creatinine (Table 4).
Regression analysis assessed the impact of hypertension, 
DM, age, baseline serum calcium, creatinine, eGFR, and 
PTH levels on eGFR changes. PTH, hypertension, or DM 
did not significantly affect eGFR change. The most signifi-
cant model (including the variables of age, baseline serum 
calcium, creatinine and eGFR levels) was Model F = 4.276; 
model R2 = 0.206; P = 0.004 (Table 5). All these variables, ex-
cept baseline serum creatinine, were independent predic-
tors of eGFR change.
diSCuSSion
This study points to an association between mild renal 
dysfunction in PHPT and older age, hypertension, and high 
serum calcium levels. In addition, older age, high basal 
eGFR, and high basal calcium levels were associated with 
a decrease in eGFR after surgery. Our findings are in ac-
cordance with those reported in previous research, which 
also found an association between low eGFR and hyper-
tension, older age, and high calcium levels, although these 
studies included patients with lower eGFR (1,4).
The most recent guideline on the management of asymp-
tomatic PHPT confirmed 60 mL/min/1.73 m2 as the renal 
impairment threshold for parathyroidectomy, which is 
equivalent to stage 3 chronic kidney disease. Below this 
level, decreased renal function may negatively affect PTH 
levels (16,17). However, some studies reported secondary 
increases in PTH levels and PHPT exacerbation at an eGFR 
threshold ranging from 30 to 70 mL/min/1.73 m2 (17-19). 
These differences might be explained by the method-
ological differences and different number of participants 
between the studies. The present study included patients 
with eGFRs ≥60 mL/min/1.73 m2 to eliminate the impact of 
renal dysfunction on PTH levels.
Several previous studies investigated the effects of para-
thyroidectomy on renal impairment. In patients with de-
creased renal function (eGFR<60 mL/min/1.73 m2), para-
thyroidectomy did not improve eGFR (6-12,19-21) but it 
did halt eGFR deterioration (4,5,19). Our study showed for 
the first time that patients with eGFR between 60 and 90 
mL/min/1.73 m2 had a preserved renal function, whereas 
those with eGFR≥90 mL/min/1.73 m2 had a decreased 
eGFR in post-parathyroidectomy period.
Nair et al (4) reported an increased prevalence of renal dys-
function when calcium levels exceeded 12 mg/dL. The risk 
of developing renal failure was increased 13.8-fold even in 
mild PHPT (mean calcium: 10.5 mg/dL) (22). To the best of 
our knowledge, this is the first study to evaluate the im-
pact of pre-surgery calcium levels on pre- and post-sur-
gery eGFR by dividing the patients according to their calci-
um levels. The results revealed that the high calcium group 
had significantly low eGFR and more common renal injury 
after parathyroidectomy than the low calcium group. This 
finding may be explained by the presence of PTH, a potent 
vasodilator of renal arteries and arterioles. Therefore, in-
creased PTH levels in PHPT may lead to increased glomer-
ular flow and increased GFR (14,23-25). In previous studies, 
increased pre-glomerular resistance after abrupt parathy-
roidectomy-related decreases in PTH levels was associat-
ed with acute renal injury (14,24-26). Although we found 
no association between PTH levels and eGFR change 3-6 
months after surgery, calcium levels were related to eGFR 
changes.
The post-parathyroidectomy eGFR decrease was more fre-
quent in the normal eGFR group and high calcium group. 
This is not a contradiction because, despite parathyroidec-
tomy, calcium remained higher in the high calcium group 
than in the low calcium group. Also, there were more pa-
tients in the high calcium group with a decrease in their 
eGFR postoperatively most probably due to the effect of 
abruptly falling PTH levels. There was no difference in cal-
cium levels between the low eGFR group and the normal 
eGFR group in the postoperative period.
The known causes of renal dysfunction include hyper-
tension, DM, and renal complications. Some studies 
taBle 5. multiple linear regression model of predictors of 
estimated glomerular filtration rate (eGFR) change between 
pre- and post-parathyroidectomy values*
independent variables Beta P
Age, years 0.531 0.021
Serum creatinine, mg/dL 0.523 0.101
Serum calcium, mg/dL 0.251 0.034
eGFR (mL/min/1.73 m2) 1.202 0.006
*dependent variable: eGFR change (continuous variable), R2 of the 
model = 0.206, P = 0.004.
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reported a significantly high prevalence of DM and hyper-
tension among PHPT patients (4,27,28). In our study, there 
was no significant difference between the groups in the DM 
rate. In addition, the patients were evaluated as soon as 3-6 
months after surgery to minimize the effects of chronic dis-
ease processes such as DM and hypertension on eGFR. A 
longer follow-up interval after surgery might have provid-
ed misleading information on eGFR changes. Some previ-
ous studies observed transient changes in renal function in 
patients with PHPT in the first 48 hours after parathyroidec-
tomy, which continued for up to 6 months (22,29). In our 
patients, there were no major surgical complications, such 
as severe hypotension. Therefore, the time interval in the 
present study was long enough to allow renal recovery af-
ter surgery.
Most previous studies that evaluated the association be-
tween PHPT and eGFR did not classify the patients accord-
ing to their pathological diagnosis (parathyroid adenoma 
or hyperplasia). We included only patients with parathy-
roid adenoma. Although there are several studies on PHPT 
and eGFR, no other study evaluated the eGFR changes af-
ter parathyroidectomy according to pre-operative calcium 
levels. We believe that this study elucidates the effects of 
parathyroidectomy and pre-operative hypercalcemia on 
eGFR more clearly in a specific group of patients with para-
thyroid adenoma and eGFR level ≥60 mL/min/1.73 m2.
Our study has several limitations, most notably its retro-
spective design and short evaluation time. In all the eGFR 
calculations, we used a single creatinine level, which may 
not reflect the actual eGFR. Our sample size was limited be-
cause of our strict inclusion criteria. Further studies on the 
effects of parathyroidectomy in a larger group of patients 
with eGFR ≥60 mL /min/1.73 m2 are needed to confirm our 
results and further explain the etiology of renal dysfunc-
tion in PHPT and eGFR changes post-surgery.
In conclusion, we believe that these data provide new in-
sight into the effect of hypercalcemia and parathyroidec-
tomy on pre- and post-parathyroidectomy eGFR levels. 
Mild renal dysfunction in PHPT was associated with old-
er age, hypertension, and high serum calcium levels. Age 
and pre-parathyroidectomy eGFR and calcium levels were 
predictors of eGFR changes after surgery. In addition, older 
age, high baseline eGFR, and high baseline calcium levels 
were associated with eGFR decrease after surgery.
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